Seeking Novel Approaches for Regulating Immunometabolism in the Treatment of Inflammatory Diseases

An immunology‑focused pharmaceutical company is seeking novel druggable targets and/or molecules that are involved in regulation of immunometabolism in inflammatory disease. Specifically, the team are looking to focus on targetable molecules with demonstrated involvement in human pathology (e.g. a role in pathways linked to disease).

Approaches of Interest:

• Approaches that dramatically alter the immune cell state (e.g. macrophage M1 to M2 transition, or Th1 to Treg transition)
• Targets that specifically express in immune cells
• Improved modulation of pathways...